This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 1998 Aug 15;352(9127):573; author reply 574-5.

doi: 10.1016/S0140-6736(05)79280-1.

Hypertension Optimal Treatment (HOT) trial

T Senderovitz, J P Kampmann

PMID: 9716082
DOI: 10.1016/S0140-6736(05)79280-1

Comment

Hypertension Optimal Treatment (HOT) trial

T Senderovitz et al. Lancet. 1998.

. 1998 Aug 15;352(9127):573; author reply 574-5.

doi: 10.1016/S0140-6736(05)79280-1.

Authors

T Senderovitz, J P Kampmann

PMID: 9716082
DOI: 10.1016/S0140-6736(05)79280-1

No abstract available

PubMed Disclaimer

Comment on

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group.
Hansson L, Zanchetti A, Carruthers SG, Dahlöf B, Elmfeldt D, Julius S, Ménard J, Rahn KH, Wedel H, Westerling S. Hansson L, et al. Lancet. 1998 Jun 13;351(9118):1755-62. doi: 10.1016/s0140-6736(98)04311-6. Lancet. 1998. PMID: 9635947 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information